Skip to content
Search

Latest Stories

Chemix Group buys Middleton Pharmacy in Darlington

Chemix Group also operates a pharmacy in Halifax
Middleton Pharmacy in Darlington ( image credit - Christie and Co)

The group, which also operates a pharmacy in Halifax, aims to expand the business and enhance healthcare services in the village 

Chemix Group, an independent contractor, has acquired a high-dispensing Darlington pharmacy, previously owned by Middleton Healthcare Limited for 22 years.

The pharmacy, located in the village of Middleton St George near a GP surgery, dispenses an average of 10,874 items per month, according to Christie and Co, which brokered the deal.


Middleton Healthcare Limited, a consortium of three GPs, decided to sell the pharmacy as part of their retirement plans, the broker said.

Chemix Group, which also owns a pharmacy in Halifax, secured the acquisition through a confidential sales process with Christie and Co.

Prashanth Takkallapally and Harendra Patel, directors at Chemix Group, shared that, being local to the area, they knew this was the right pharmacy to add to their expanding group.

“We look forward to growing the business and implementing our plans to improve healthcare in the village,” they said.

Patrick Holmes, the former owner of Middleton Pharmacy, expressed satisfaction with the sale, saying, “We are very happy with the outcome of handing over the business to new owners and keeping the business local.

“We are confident they will provide excellent care and service to the local community going forward.”

Karl Clezy, director – pharmacy at Christie and Co, revealed that the high level of interest in the pharmacy, with three offers received within the first two weeks on the market.

“The buyers could see that the pharmacy had a lot of potential to improve its trading performance,” he said.

Skelton Pharmacy Image credit: Christie and Co

The broker has also announced the sale of Skelton Pharmacy in Saltburn-by-the-Sea, North Yorkshire, which has been acquired by a local first-time buyer, who will run the business as the owner-Pharmacist.

Located in the town centre of Skelton-in-Cleveland, it is a well-performing community pharmacy that dispenses an average of circa 8,500 NHS items per month.

Previously owned for 11 years by group operator Zulfiqar Rafiq, the pharmacy was mainly run by locum pharmacists.

Rafiq decided to sell the business to focus on his three other pharmacies in Middlesbrough, according to Christie and Co.

Expressing his best wishes to the new owner, Rafiq stated: “He is buying a thriving and growing business with excellent staff and loyal patient base.”

Karl noted that pharmacy mainly attracted interest from first-time buyers due to the affordable price level.

“We placed the pharmacy on the market in the middle of February this year and we successfully agreed a deal after the first week in March,” he added.

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less